AstraZeneca said Monday that late stage trials of its COVID-19 vaccine developed with Oxford University were “highly effective” in preventing disease.

The coronavirus vaccine developed by the University of Oxford stops 70% of people developing Covid symptoms, a large scale trial shows, reports BBC.

Pfizer formally asked U.S. regulators Friday to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.

Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live.

A Chinese inactivated COVID-19 vaccine candidate has been proved safe and tolerable and can induce a quick immune response, according to the findings from early and mid-stage clinical trials published in the journal The Lancet Infectious Diseases.

Gliding over significant challenges still to come, President Donald Trump offered a rosy update on the race for a vaccine for the resurgent coronavirus as he delivered his first public remarks since his defeat by President-elect Joe Biden. He still did not concede the election.

Chinese and German researchers, in a recently-published study,  have suggested that Shufeng Jiedu capsules, a patented herbal drug composed of eight medicinal plants, might be "a promising herbal therapy for moderate COVID-19."

Xiamen Innovax Biotech Co. Ltd., a subsidiary of China's Yangshengtang Group in eastern China's Zhejiang Province and Xiamen University have announced cooperation with British pharmaceutical giant GlaxoSmithKline (GSK), to do an evaluation for a recombinant protein-based vaccine candidate for COVID-19.